Mark R. Brunswick

SVP, Regulatory Affairs at Sorrento Therapeutics

Dr. Brunswick has over 35 years of senior positions in Regulated Industry including over 9 years in the US FDA, Center for Biologics, Division of Monoclonal Antibodies.

Org chart

Manager

Henry Ji

Chairman, President & CEO

Peers

Shawn Sahebi

SVP, Commercial Operations

Xiao Xu

President, ACEA

Jeffrey Su

EVP & COO

Reports

Gloria Lam

Regulatory Affairs Manager

Stacy Park

Associate General Counsel

Teams

CEO and Executive Team

3 members

Leadership Team

4 members

Timeline

SVP, Regulatory Affairs
Current role

View in org chart